Context, not class, may be the key signal in systemic JAK inhibitor exposure in MF/SS

Clicks: 1
ID: 317364
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #199 of 302 articles by views in the british journal of dermatology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 302 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
This letter argues that the apparent risk signal associated with systemic JAK inhibitors in mycosis fungoides/Sézary syndrome should be interpreted in light of clinical context, heterogeneous case sources, and diagnostic uncertainty. It highlights late-onset or erythrodermic dermatitis and the post-transplant setting as higher-risk contexts, while cautioning against assuming a uniform harmful class effect.
Reference Key
openalex_W7164733694 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Yixuan He, Changqiang Li
Journal the british journal of dermatology
Year 2026
DOI
10.1093/bjd/ljag238
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.